<DOC>
	<DOCNO>NCT02835651</DOCNO>
	<brief_summary>The purpose study determine whether palmitic acid ( C16:0 ) stearic acid ( C18:0 ) different effect HDL metabolism fast state .</brief_summary>
	<brief_title>Saturated Fatty Acids HDL Metabolism</brief_title>
	<detailed_description>Study design : Double blind , randomize , cross-over study two different diet : one diet high palmitic acid ( C16:0 ) diet high stearic acid ( C18:0 ) . Subjects receive diet 4 week wash-out period 4-6 week . Contrast intakes palmitic acid stearic acid 6 % energy . A postprandial test carry end dietary period . Study population : Accounting dropout rate 20 % , 40 healthy men postmenopausal woman , age 45 70 year , BMI ( body mass index ) ≥ 18.0 ≤ 30.0 kg/m2 recruit .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Palmitic Acid</mesh_term>
	<criteria>Apparently healthy men postmenopausal woman ( postmenopausal least one year ) judge study physician BMI ≥ 18.0 ≤ 30.0 kg/m2 Aged 45 70 year Willing comply study protocol study Having general practitioner Agreeing inform medically relevant personal testresults physician Informed consent sign Accessible vein arm determine examination screen Having medical condition might impact study measurement Use overthecounter prescribed medication , may interfere study measurement Use oral antibiotic 40 day less prior start study ; Use food supplement plantsterol/stanolenriched food supplement three month prior screen and/or study ; Reported alcohol consumption ≥ 10 units/week ( female ) ≥ 14 units/week ( male ) ; Reported intense sporting activity ≥ 10 hours/week ; Reported weight loss gain 3 kg period 2 month prior screen Regular smoker ( least one cigarette ( equivalent ) daily &gt; 7 cigarette ( equivalent ) weekly . Smokers comfortably restrain smoke 2 day also exclude Reported dietary habit : medically prescribe diet , allergy/intolerance test product provide study Blood donation past 3 month Drug abuse Reported participation another nutritional biomedical trial 3 month prior screen Fasting triacylglycerol concentration screen : ≥ 4.5 mmol/L Serum lipid : treatment recommend accord `` Multidisciplinary guideline Cardiovascular risk management '' Fasting HbA1c ≥ 48 mmol/mol ( 6.5 % )</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Palmitic acid</keyword>
	<keyword>Stearic acid</keyword>
	<keyword>HDL-metabolism</keyword>
	<keyword>Human intervention study</keyword>
</DOC>